Table of Contents Chapter 1 Overview of Androgens 1.1 Definition of Androgens in This Report 1.2 Commercial Types of Androgens 1.2.1 Solution 1.2.2 Implant 1.2.3 Capsule 1.2.4 Kit 1.2.5 Tablet 1.2.6 Other 1.3 Downstream Application of Androgens 1.3.1 Anemias 1.3.2 Delayed Growth Spurt 1.3.3 Lichen Sclerosus 1.3.4 Microphallus 1.3.5 Other 1.4 Development History of Androgens 1.5 Market Status and Trend of Androgens 2013-2023 1.5.1 Global Androgens Market Status and Trend 2013-2023 1.5.2 Regional Androgens Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Androgens 2013-2017 2.2 Sales Market of Androgens by Regions 2.2.1 Sales Volume of Androgens by Regions 2.2.2 Sales Value of Androgens by Regions 2.3 Production Market of Androgens by Regions 2.4 Global Market Forecast of Androgens 2018-2023 2.4.1 Global Market Forecast of Androgens 2018-2023 2.4.2 Market Forecast of Androgens by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Androgens by Types 3.2 Sales Value of Androgens by Types 3.3 Market Forecast of Androgens by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Androgens by Downstream Industry 4.2 Global Market Forecast of Androgens by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Androgens Market Status by Countries 5.1.1 North America Androgens Sales by Countries (2013-2017) 5.1.2 North America Androgens Revenue by Countries (2013-2017) 5.1.3 United States Androgens Market Status (2013-2017) 5.1.4 Canada Androgens Market Status (2013-2017) 5.1.5 Mexico Androgens Market Status (2013-2017) 5.2 North America Androgens Market Status by Manufacturers 5.3 North America Androgens Market Status by Type (2013-2017) 5.3.1 North America Androgens Sales by Type (2013-2017) 5.3.2 North America Androgens Revenue by Type (2013-2017) 5.4 North America Androgens Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Androgens Market Status by Countries 6.1.1 Europe Androgens Sales by Countries (2013-2017) 6.1.2 Europe Androgens Revenue by Countries (2013-2017) 6.1.3 Germany Androgens Market Status (2013-2017) 6.1.4 UK Androgens Market Status (2013-2017) 6.1.5 France Androgens Market Status (2013-2017) 6.1.6 Italy Androgens Market Status (2013-2017) 6.1.7 Russia Androgens Market Status (2013-2017) 6.1.8 Spain Androgens Market Status (2013-2017) 6.1.9 Benelux Androgens Market Status (2013-2017) 6.2 Europe Androgens Market Status by Manufacturers 6.3 Europe Androgens Market Status by Type (2013-2017) 6.3.1 Europe Androgens Sales by Type (2013-2017) 6.3.2 Europe Androgens Revenue by Type (2013-2017) 6.4 Europe Androgens Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Androgens Market Status by Countries 7.1.1 Asia Pacific Androgens Sales by Countries (2013-2017) 7.1.2 Asia Pacific Androgens Revenue by Countries (2013-2017) 7.1.3 China Androgens Market Status (2013-2017) 7.1.4 Japan Androgens Market Status (2013-2017) 7.1.5 India Androgens Market Status (2013-2017) 7.1.6 Southeast Asia Androgens Market Status (2013-2017) 7.1.7 Australia Androgens Market Status (2013-2017) 7.2 Asia Pacific Androgens Market Status by Manufacturers 7.3 Asia Pacific Androgens Market Status by Type (2013-2017) 7.3.1 Asia Pacific Androgens Sales by Type (2013-2017) 7.3.2 Asia Pacific Androgens Revenue by Type (2013-2017) 7.4 Asia Pacific Androgens Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Androgens Market Status by Countries 8.1.1 Latin America Androgens Sales by Countries (2013-2017) 8.1.2 Latin America Androgens Revenue by Countries (2013-2017) 8.1.3 Brazil Androgens Market Status (2013-2017) 8.1.4 Argentina Androgens Market Status (2013-2017) 8.1.5 Colombia Androgens Market Status (2013-2017) 8.2 Latin America Androgens Market Status by Manufacturers 8.3 Latin America Androgens Market Status by Type (2013-2017) 8.3.1 Latin America Androgens Sales by Type (2013-2017) 8.3.2 Latin America Androgens Revenue by Type (2013-2017) 8.4 Latin America Androgens Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Androgens Market Status by Countries 9.1.1 Middle East and Africa Androgens Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Androgens Revenue by Countries (2013-2017) 9.1.3 Middle East Androgens Market Status (2013-2017) 9.1.4 Africa Androgens Market Status (2013-2017) 9.2 Middle East and Africa Androgens Market Status by Manufacturers 9.3 Middle East and Africa Androgens Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Androgens Sales by Type (2013-2017) 9.3.2 Middle East and Africa Androgens Revenue by Type (2013-2017) 9.4 Middle East and Africa Androgens Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Androgens 10.1 Global Economy Situation and Trend Overview 10.2 Androgens Downstream Industry Situation and Trend Overview Chapter 11 Androgens Market Competition Status by Major Manufacturers 11.1 Production Volume of Androgens by Major Manufacturers 11.2 Production Value of Androgens by Major Manufacturers 11.3 Basic Information of Androgens by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Androgens Major Manufacturer 11.3.2 Employees and Revenue Level of Androgens Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Androgens Major Manufacturers Introduction and Market Data 12.1 Pfizer 12.1.1 Company profile 12.1.2 Representative Androgens Product 12.1.3 Androgens Sales, Revenue, Price and Gross Margin of Pfizer 12.2 Sanofi-Aventis 12.2.1 Company profile 12.2.2 Representative Androgens Product 12.2.3 Androgens Sales, Revenue, Price and Gross Margin of Sanofi-Aventis 12.3 Abbott 12.3.1 Company profile 12.3.2 Representative Androgens Product 12.3.3 Androgens Sales, Revenue, Price and Gross Margin of Abbott 12.4 Dendreon 12.4.1 Company profile 12.4.2 Representative Androgens Product 12.4.3 Androgens Sales, Revenue, Price and Gross Margin of Dendreon 12.5 AstraZeneca 12.5.1 Company profile 12.5.2 Representative Androgens Product 12.5.3 Androgens Sales, Revenue, Price and Gross Margin of AstraZeneca 12.6 Anabolics 12.6.1 Company profile 12.6.2 Representative Androgens Product 12.6.3 Androgens Sales, Revenue, Price and Gross Margin of Anabolics 12.7 ABBVIE 12.7.1 Company profile 12.7.2 Representative Androgens Product 12.7.3 Androgens Sales, Revenue, Price and Gross Margin of ABBVIE 12.8 Wuhan Nuohui Pharmaceutical And Chwmical 12.8.1 Company profile 12.8.2 Representative Androgens Product 12.8.3 Androgens Sales, Revenue, Price and Gross Margin of Wuhan Nuohui Pharmaceutical And Chwmical Chapter 13 Upstream and Downstream Market Analysis of Androgens 13.1 Industry Chain of Androgens 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Androgens 14.1 Cost Structure Analysis of Androgens 14.2 Raw Materials Cost Analysis of Androgens 14.3 Labor Cost Analysis of Androgens 14.4 Manufacturing Expenses Analysis of Androgens Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Solution Table Advantage and Disadvantage of Implant Table Advantage and Disadvantage of Capsule Table Advantage and Disadvantage of Kit Table Advantage and Disadvantage of Tablet Table Advantage and Disadvantage of Other Table Sales Volume of Androgens by Regions 2013-2017 Table Sales Value of Androgens by Regions 2013-2017 Table Production Volume of Androgens by Regions 2013-2017 Table Global Sales Volume of Androgens by Regions 2018-2023 Table Global Sales Value of Androgens by Regions 2018-2023 Table Global Production Volume of Androgens by Regions 2018-2023 Table Sales Volume of Androgens by Types 2013-2017 Table Sales Value of Androgens by Types 2013-2017 Table Sales Volume Forecast of Androgens by Types 2018-2023 Table Sales Value Forecast of Androgens by Types 2018-2023 Table Sales Volume of Androgens by Downstream Industry 2013-2017 Table Sales Volume Forecast of Androgens by Downstream Industry 2018-2023 Table North America Androgens Sales by Countries (2013-2017) Table North America Androgens Sales Share by Countries (2013-2017) Table North America Androgens Revenue by Countries (2013-2017) Table North America Androgens Revenue Market Share by Countries (2013-2017) Table North America Androgens Sales by Type (2013-2017) Table North America Androgens Sales Share by Type (2013-2017) Table North America Androgens Revenue by Type (2013-2017) Table North America Androgens Revenue Share by Type (2013-2017) Table North America Androgens Sales by Downstream Industry (2013-2017) Table North America Androgens Sales Share by Downstream Industry (2013-2017) Table Europe Androgens Sales by Countries (2013-2017) Table Europe Androgens Sales Share by Countries (2013-2017) Table Europe Androgens Revenue by Countries (2013-2017) Table Europe Androgens Revenue Market Share by Countries (2013-2017) Table Europe Androgens Sales by Type (2013-2017) Table Europe Androgens Sales Share by Type (2013-2017) Table Europe Androgens Revenue by Type (2013-2017) Table Europe Androgens Revenue Share by Type (2013-2017) Table Europe Androgens Sales by Downstream Industry (2013-2017) Table Europe Androgens Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Androgens Sales by Countries (2013-2017) Table Asia Pacific Androgens Sales Share by Countries (2013-2017) Table Asia Pacific Androgens Revenue by Countries (2013-2017) Table Asia Pacific Androgens Revenue Market Share by Countries (2013-2017) Table Asia Pacific Androgens Sales by Type (2013-2017) Table Asia Pacific Androgens Sales Share by Type (2013-2017) Table Asia Pacific Androgens Revenue by Type (2013-2017) Table Asia Pacific Androgens Revenue Share by Type (2013-2017) Table Asia Pacific Androgens Sales by Downstream Industry (2013-2017) Table Asia Pacific Androgens Sales Share by Downstream Industry (2013-2017) Table Latin America Androgens Sales by Countries (2013-2017) Table Latin America Androgens Sales Share by Countries (2013-2017) Table Latin America Androgens Revenue by Countries (2013-2017) Table Latin America Androgens Revenue Market Share by Countries (2013-2017) Table Latin America Androgens Sales by Type (2013-2017) Table Latin America Androgens Sales Share by Type (2013-2017) Table Latin America Androgens Revenue by Type (2013-2017) Table Latin America Androgens Revenue Share by Type (2013-2017) Table Latin America Androgens Sales by Downstream Industry (2013-2017) Table Latin America Androgens Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Androgens Sales by Regions (2013-2017) Table Middle East and Africa Androgens Sales Share by Regions (2013-2017) Table Middle East and Africa Androgens Revenue by Regions (2013-2017) Table Middle East and Africa Androgens Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Androgens Sales by Type (2013-2017) Table Middle East and Africa Androgens Sales Share by Type (2013-2017) Table Middle East and Africa Androgens Revenue by Type (2013-2017) Table Middle East and Africa Androgens Revenue Share by Type (2013-2017) Table Middle East and Africa Androgens Sales by Downstream Industry (2013-2017) Table Middle East and Africa Androgens Sales Share by Downstream Industry (2013-2017) Table Production Volume of Androgens by Major Manufacturers 2013-2017 Table Production Value of Androgens by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Androgens Major Manufacturer Table Employees and Revenue Level of Androgens Major Manufacturer Table Representative Androgens Product One of Pfizer Table Representative Androgens Product Two of Pfizer Table Androgens Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Androgens Product One of Sanofi-Aventis Table Representative Androgens Product Two of Sanofi-Aventis Table Androgens Sales, Revenue, Price and Gross Margin of Sanofi-Aventis 2013-2017 Table Representative Androgens Product One of Abbott Table Representative Androgens Product Two of Abbott Table Androgens Sales, Revenue, Price and Gross Margin of Abbott 2013-2017 Table Representative Androgens Product One of Dendreon Table Representative Androgens Product Two of Dendreon Table Androgens Sales, Revenue, Price and Gross Margin of Dendreon 2013-2017 Table Representative Androgens Product One of AstraZeneca Table Representative Androgens Product Two of AstraZeneca Table Androgens Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017 Table Representative Androgens Product One of Anabolics Table Representative Androgens Product Two of Anabolics Table Androgens Sales, Revenue, Price and Gross Margin of Anabolics 2013-2017 Table Representative Androgens Product One of ABBVIE Table Representative Androgens Product Two of ABBVIE Table Androgens Sales, Revenue, Price and Gross Margin of ABBVIE 2013-2017 Table Representative Androgens Product One of Wuhan Nuohui Pharmaceutical And Chwmical Table Representative Androgens Product Two of Wuhan Nuohui Pharmaceutical And Chwmical Table Androgens Sales, Revenue, Price and Gross Margin of Wuhan Nuohui Pharmaceutical And Chwmical 2013-2017